Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities

@article{Jakobsen2018AssociationOB,
  title={Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities},
  author={Gunn Signe Jakobsen and Milada Cvancarova Sm{\aa}stuen and Rune Sandbu and Njord Nordstrand and Dag Hofs{\o} and Morten Lindberg and Jens Kristoffer Hertel and J{\o}ran Hjelmes{\ae}th},
  journal={JAMA},
  year={2018},
  volume={319},
  pages={291–301}
}
Importance The association of bariatric surgery and specialized medical obesity treatment with beneficial and detrimental outcomes remains uncertain. Objective To compare changes in obesity-related comorbidities in patients with severe obesity (body mass index ≥40 or ≥35 and at least 1 comorbidity) undergoing bariatric surgery or specialized medical treatment. Design, Setting, and Participants Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data… 

Figures and Tables from this paper

Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension
TLDR
RYGB is an effective strategy for midterm BP control and hypertension remission, with fewer medications required in patients with hypertension and obesity.
Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: A systematic review and meta-analysis
TLDR
It is suggested that broader access to bariatric surgery for people with obesity may reduce the long-term sequelae of this disease and provide population-level benefits and Limitations of the study include that it was not possible to account for unmeasured variables.
Setting Appropriate Expectations After Bariatric Surgery: Evaluating Weight Regain and Clinical Outcomes.
TLDR
Recommendations for how to best measure clinically important weight regain after bariatric surgery based on Longitudinal Assessment of Bariatric Surgery (LABS) study outcomes are provided and can guide future investigations ofbariatric surgery weight regain by establishing a standard measure and definition for weight regain.
Association between metabolic surgery and cardiovascular outcome in patients with hypertension: A nationwide matched cohort study
TLDR
Metabolic surgery on patients with morbid obesity and pharmacologically treated hypertension was associated with lower risk for MACEs and all-cause mortality compared with age- and sex-matched controls with hypertension from the general population.
Bariatric Surgery in the Elderly Patient: Safety and Short-time Outcome. A Case Match Analysis
TLDR
Although the sample size is small to draw definitive conclusions, bariatric surgery in patients 65 years or older seems to be safe, with similar outcomes and complication rates as in younger patients, regardless of procedure performed.
Associations between Lifetime Adversity and Obesity Treatment in Patients with Morbid Obesity
TLDR
It is suggested that decisions concerning obesity treatment should include dialogue-based assessments of the patients’ lifetime adversity, as increasing BMI, DM2, and joint pain were all associated with treatment choice for obesity.
Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation.
TLDR
Roux-en-Y gastric bypass was costly to deliver, but it was the most cost-effective intervention, and most WMPs were cost- effective compared with current population obesity trends.
Safety and Efficacy of Bariatric and Metabolic Surgery
TLDR
The current bariatric procedures produce significant and durable weight loss and reduce the morbidity and mortality associated with obesity-related diseases substantially, and the risk/benefit ratio for bariatric surgery is decidedly in favor for the benefit.
The effect of bariatric surgery in comparison with the control group on the prevention of comorbidities in people with severe obesity: a prospective cohort study
TLDR
The risk reduction of obesity-related comorbidities afterbariatric surgery should be considered in the decision-making process for public health in the region, which bariatric surgery could result in the prevention of comorbridities.
Arterial Hypertension in Morbid Obesity after Bariatric Surgery: Five Years of Follow-Up, a Before-And-After Study
TLDR
LRYGB in obese patients is associated with a remission of HTN, and no weight loss differences were observed between the group of patients showing HTN remission at two years and the group who did not, however, differences were seen after the second follow-up year, with an increased weight loss in the remission group, which could indicate that sustained weight loss favours the control of HTn.
...
...

References

SHOWING 1-10 OF 73 REFERENCES
Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care
TLDR
Bariatric surgery as delivered in the UK healthcare system is associated with dramatic weight loss, sustained at least 4 y after surgery, accompanied by substantial improvements in pre-existing T2DM and hypertension, as well as a reduced risk of incident T2 DM, hypertension, angina, MI, and obstructive sleep apnoea.
The Impact of Bariatric Surgery on Comorbidities and Medication Use Among Obese Patients
TLDR
Bariatric surgery was associated with significant reductions in reported claims for short- and long-term health outcomes and reduced medication use for major disease categories.
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials
TLDR
Compared with non-surgical treatment of obesity, bariatric surgery leads to greater body weight loss and higher remission rates of type 2 diabetes and metabolic syndrome and greater improvements in quality of life and reductions in medicine use.
Health benefits of gastric bypass surgery after 6 years.
TLDR
Among severely obese patients, compared with nonsurgical control patients, the use of RYGB surgery was associated with higher rates of diabetes remission and lower risk of cardiovascular and other health outcomes over 6 years.
Morbidly Obese Patients—Who Undergoes Bariatric Surgery?
TLDR
The data indicates that increasing BMI rather than obesity-related comorbidities, predicted treatment choice in morbidly obese patients.
Long-term follow-up after bariatric surgery: a systematic review.
TLDR
Gastric bypass has better outcomes than gastric band procedures for long-term weight loss, type 2 diabetes control and remission, hypertension, and hyperlipidemia, and insufficient evidence exists regarding long- term outcomes for gastric sleeve resections.
The association between severity of King’s Obesity Staging Criteria scores and treatment choice in patients with morbid obesity: a retrospective cohort study
TLDR
BMI was the strongest KOSC-domain associated with subsequent bariatric surgery after a shared decision making process and Prospective studies are required to assess whether the use of K OSC can help guide patients and clinicians to identify the most appropriate choice of treatment for morbid obesity.
Medication Use Patterns after Gastric Bypass Surgery for Weight Management
TLDR
Bariatric surgery has a positive benefit in terms of reduction intake of medication associated with obesity-related comorbid disease, however, there is limited reduction in the overall number of drugs and supplements being consumed by the patient, especially during the first year postoperatively.
Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
TLDR
Type 2 diabetes and obesity-related cardiovascular risk factors were improved after both treatment strategies, however, the improvements were greatest in those patients treated with gastric bypass surgery.
Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study.
...
...